T. Perpoint

1.0k total citations
17 papers, 313 citations indexed

About

T. Perpoint is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, T. Perpoint has authored 17 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Infectious Diseases and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in T. Perpoint's work include Tuberculosis Research and Epidemiology (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Streptococcal Infections and Treatments (3 papers). T. Perpoint is often cited by papers focused on Tuberculosis Research and Epidemiology (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Streptococcal Infections and Treatments (3 papers). T. Perpoint collaborates with scholars based in France, Morocco and Belgium. T. Perpoint's co-authors include Tristan Ferry, Gérard Lina, François Vandenesch, Jérôme Étienne, D. Peyramond, I. Mohammédi, Frédéric Laurent, Grégory Resch, Christian Chidiac and Sarah Djebara and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

T. Perpoint

17 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Perpoint France 9 134 79 72 62 55 17 313
Mwila Kabwe Australia 12 214 1.6× 247 3.1× 114 1.6× 88 1.4× 56 1.0× 28 523
I Heinzer Switzerland 11 114 0.9× 169 2.1× 54 0.8× 41 0.7× 130 2.4× 19 415
Marcia A. Kielhofner United States 11 148 1.1× 115 1.5× 30 0.4× 75 1.2× 27 0.5× 15 390
Kentaro Nagaoka Japan 10 98 0.7× 103 1.3× 15 0.2× 57 0.9× 27 0.5× 43 326
Leonid Titov Belarus 16 272 2.0× 285 3.6× 29 0.4× 28 0.5× 57 1.0× 62 585
Julien Goret France 10 140 1.0× 261 3.3× 30 0.4× 26 0.4× 166 3.0× 26 468
Hagai Rechnitzer Israel 11 39 0.3× 124 1.6× 31 0.4× 68 1.1× 110 2.0× 24 347
Michelle Francis Australia 11 159 1.2× 139 1.8× 12 0.2× 33 0.5× 20 0.4× 19 338
Berna Gültekın Türkiye 9 170 1.3× 58 0.7× 50 0.7× 24 0.4× 25 0.5× 27 406
Beatriz Perazzi Argentina 10 98 0.7× 87 1.1× 11 0.2× 37 0.6× 92 1.7× 38 272

Countries citing papers authored by T. Perpoint

Since Specialization
Citations

This map shows the geographic impact of T. Perpoint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Perpoint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Perpoint more than expected).

Fields of papers citing papers by T. Perpoint

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Perpoint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Perpoint. The network helps show where T. Perpoint may publish in the future.

Co-authorship network of co-authors of T. Perpoint

This figure shows the co-authorship network connecting the top 25 collaborators of T. Perpoint. A scholar is included among the top collaborators of T. Perpoint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Perpoint. T. Perpoint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ferry, Tristan, Camille Kolenda, Frédéric Laurent, et al.. (2022). Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection. Nature Communications. 13(1). 4239–4239. 91 indexed citations
2.
Valour, Florent, Oana Dumitrescu, Jérôme Dumortier, et al.. (2018). A practical approach to tuberculosis diagnosis and treatment in liver transplant recipients in a low-prevalence area. Médecine et Maladies Infectieuses. 49(4). 231–240. 8 indexed citations
3.
Triffault-Fillit, Claire, Tristan Ferry, T. Perpoint, et al.. (2017). Outpatient parenteral antibiotic therapy: Evaluation of practices and limits of use in rural areas in France. Médecine et Maladies Infectieuses. 48(2). 130–135. 8 indexed citations
4.
Tristan, Anne, Florent Valour, T. Perpoint, et al.. (2017). Actinomycose disséminée traitée par clindamycine. Archives de Pédiatrie. 24(5). 460–463. 1 indexed citations
5.
Catho, Gaud, S. Couraud, S. Grard, et al.. (2015). Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting. Clinical Microbiology and Infection. 21(5). 472.e7–472.e10. 4 indexed citations
6.
Catho, Gaud, A. Sénéchal, Florent Valour, et al.. (2015). Enfants au contact d’individus atteints d’une tuberculose multi-résistante : quelles stratégies adopter ? Analyse de 46 enfants contacts et revue de la littérature. Revue de Pneumologie Clinique. 71(6). 335–341. 4 indexed citations
7.
Folliet, Laure, T. Perpoint, Frédéric Laurent, et al.. (2015). Actinomycose bronchique pseudo-tumorale simulant une ré-évolution d’un cancer bronchique 14ans après la prise en charge thérapeutique initiale : à propos d’un cas. Revue des Maladies Respiratoires. 32(5). 524–529. 3 indexed citations
8.
Saison, Julien, Tristan Ferry, Julie Demaret, et al.. (2014). Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients. Clinical & Experimental Immunology. 176(3). 401–409. 26 indexed citations
9.
Perpoint, T., Yvan Jamilloux, Élodie Descloux, et al.. (2013). PCR-confirmed Legionella non-pneumophila meningoencephalitis. Médecine et Maladies Infectieuses. 43(1). 32–34. 4 indexed citations
10.
Haÿs, Stéphane, T. Perpoint, Marion Valette, et al.. (2011). Grippe A H1N1 en unité de néonatologie : analyse et enseignements. Archives de Pédiatrie. 18(10). 1069–1075. 1 indexed citations
11.
Valour, Florent, Sandrine Boisset, Laure Lebras, et al.. (2010). Clostridium sordellii Brain Abscess Diagnosed by 16S rRNA Gene Sequencing. Journal of Clinical Microbiology. 48(9). 3443–3444. 10 indexed citations
12.
Ferry, Tristan, Damien Thomas, T. Perpoint, et al.. (2008). Analysis of superantigenic toxin Vβ T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock. Clinical Microbiology and Infection. 14(6). 546–554. 39 indexed citations
13.
Thomas, Damien, T. Perpoint, Olivier Dauwalder, et al.. (2008). In vivo and in vitro detection of a superantigenic toxin Vbeta signature in two forms of streptococcal toxic shock syndrome. European Journal of Clinical Microbiology & Infectious Diseases. 28(6). 671–676. 12 indexed citations
14.
Descloux, Élodie, T. Perpoint, Tristan Ferry, et al.. (2007). One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. European Journal of Clinical Microbiology & Infectious Diseases. 27(1). 37–43. 47 indexed citations
15.
Valour, Florent, Laurence Maulin, Florence Ader, et al.. (2006). Vaccination contre la grippe : résultats d'une enquête sur la couverture vaccinale du personnel hospitalier à l'hôpital de la Croix-Rousse (hôpitaux de Lyon). Médecine et Maladies Infectieuses. 37(1). 51–60. 17 indexed citations
16.
Perpoint, T., et al.. (2006). Secondary Pulmonary Syphilis: Report of A Likely Case and Literature Review. Clinical Infectious Diseases. 42(3). e11–e15. 27 indexed citations
17.
Perpoint, T., Gérard Lina, Claire Poyart, et al.. (2004). Two Cases of Fatal Shock after Transfusion of Platelets Contaminated by Staphylococcus aureus: Role of Superantigenic Toxins. Clinical Infectious Diseases. 39(10). e106–e109. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mwila Kabwe Breakdown of academic impact, for papers by I Heinzer Breakdown of academic impact, for papers by Marcia A. Kielhofner Breakdown of academic impact, for papers by Kentaro Nagaoka Breakdown of academic impact, for papers by Leonid Titov Breakdown of academic impact, for papers by Julien Goret Breakdown of academic impact, for papers by Hagai Rechnitzer Breakdown of academic impact, for papers by Michelle Francis Breakdown of academic impact, for papers by Berna Gültekın Breakdown of academic impact, for papers by Beatriz Perazzi
Rankless by CCL
2026